Market research
BEAT Heartbeam Inc
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 28M
- P/E ratio
- Not available
- Analyst target
- 3.375
- Dividend yield
- Not available
- Beta
- -0.79
Community
Investor discussion
1 comment
Sign in to join the BEAT discussion.
5 years, 4 months ago
BioTelemetry, Inc is currently in a long term uptrend where the price is trading 34.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.0.
BioTelemetry, Inc's total revenue rose by 3.0% to $115M since the same quarter in the previous year.
Its net income has dropped by 18.9% to $7M since the same quarter in the previous year.
Finally, its free cash flow grew by 25.3% to $11M since the same quarter in the previous year.
Based on the above factors, BioTelemetry, Inc gets an overall score of 4/5.